Update on the Management of Rheumatoid Arthritis with Special Emphasis on Biologic Agents
Venue: Web-based program
|Event Date/Time: Nov 11, 2002||End Date/Time: Nov 01, 2003|
At the conclusion of the course the participant will be able to:
1. UNDERSTAND the indications for the use of biologic response modifiers (BRM)
2. APPRECIATE the potential side effects from and optimal monitoring for Biologic response modifiers
3. DEFINE the appropriate outcomes needed to assess the effectiveness of BRM
4. UNDERSTAND how the BRMs are incorporated into the treatment armamentarium for RA and other systemic inflammatory disorders
Weill Medical College of Cornell University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
Weill Medical College of Cornell University designates this educational activity for a maximum of 1 credit hours in Category 1 towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
AAPA accepts AMA Category 1 credit for the PRA from organizations accredited by ACCME.